Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Explore a variety of travel cards that charge no annual fees. Save on costs while maximizing your travel rewards.
26,784 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
A new $6 billion prize pool is attracting tech giants as they vie for breakthroughs in AI-safe security, cloud resili...
A tariff surge prompts a Monopoly game importer to rethink domestic production. The move highlights the cost, time an...
Sen. JD Vance faulted the Trump administration's handling of Epstein-related documents, calling out missteps in commu...
When memory stocks spark market optimism, chipmakers can drive broader gains. This piece breaks down what’s behind th...
Bitcoin breaks a 12-year trend against gold, signaling a shift in risk sentiment as quantum-era concerns enter mainst...
Oil remains a core part of global energy, and a patient, rules-based approach can reward investors. This article buil...
Meta platforms just gave a crucial signal about AI-driven cloud demand. This piece breaks down why Nebius could stand...
In the wake of the State Of The Union address, mortgage rates danced around 6% as markets priced in housing policy si...
Caterpillar dominates with record quarterly revenue fueled by data-center power needs, while Deere delivers a solid b...
D-Wave QBTS delivered a notable Q4 2025 run, with rising revenue and expanding services. This story breaks down what ...
A new wave of consumer action challenges Big Tech by urging people to purge subscriptions and rethink their spending ...